Does mucosal healing impact patient outcomes long-term?

Inflammatory Bowel Diseases

Volumn 14, Issue 4, 2008, Pages 577-578

  Van Assche, Gert ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE; PURINE DERIVATIVE;

CROHN DISEASE; ENDOSCOPY; ENTERITIS; FOLLOW UP; HEALING; HUMAN; INTESTINE MUCOSA; LONG TERM CARE; NOTE; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; ULCER HEALING; ULCERATIVE COLITIS;

EID: 42449125213     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20351     Document Type: Note

References (6)

1. Frøslie K, Jahnsen J, Moum BA, et al, and the IBSEN group. Mucosal healing in inflammatory bowel disease: results from a norwegian population-based cohort. Gastroenterology. 2007;133:412-422.
2. Rutgeerts P, Vermeire S, Van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut. 2007;56:453-455.
3. Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology. 1990;98:811-818.
4. D'Haens G, Geboes K, Rutgeerts P. Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. Gastrointest Endosc. 1999;50:667-671.
5. Colombel JF, Lemann M, Bouhnik Y, et al. The Getaid endoscopic healing of Crohn's ileo-colitis with azathioprine. Gastroenterology. 2003;124:A196,S1331.
6. Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc. 2006;63:433-442.